Cahill represented the lead arrangers in the transaction.BioMarin Pharmaceutical Inc. completed an amendment to the $200,000,000 revolving credit facility. Proceeds from the credit facility will be used…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now